聚乙胺) 结构对前列腺癌治疗性质和药物输送的影响
Junfu Zhang1, Liying Wang2, Mengting Ding1
1Department of Urology, Kidney and Urology Center, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China.
BME frontiers
|October 18, 2023
概括
研究人员开发了基于氨酸的聚胺 (Phe-PEAs) 用于向癌症治疗. 这些新型聚合物,当制成纳米颗粒时,在临床前模型中证明了改善药物输送和减少副作用.
科学领域:
- 聚合物化学 聚合物化学
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
背景情况:
- 聚合物纳米颗粒 (NP) 通过提高药物疗效和降低毒性,显示出对癌症治疗的希望.
- 优化NP药物递送需要了解聚合物结构,特性和性能之间的联系.
研究的目的:
- 为癌症治疗创建基于氨酸的聚胺 (Phe-PEAs) 的图书馆.
- 研究Phe-PEAs的结构-性质关系及其对纳米粒子药物递送效率的影响.
主要方法:
- 通过修改二醇成分的甲基基长度来合成一系列的Phe-PEAs.
- 在前列腺癌模型中为多克索鲁比辛 (DOX) 输送的纳米颗粒配制的Phe-PEAs.
- 评估了纳米粒子特性,药物负载,细胞吸收,细胞毒性和体内疗效.
主要成果:
- 在Phe-PEAs中的结构修改改变了疏水性和热性质,影响了NP大小,药物负载和细胞相互作用.
- 载有DOX的Phe-PEANP在前列腺瘤的小鼠中表现出增强的瘤抑制和减少副作用.
结论:
- Phe-PEAs提供可调节的结构,用于定制的纳米载体设计.
- 这种聚合物库和NP平台显示了通过改善药物输送来推进癌症治疗的巨大潜力.
更多相关视频
10:53Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions
Published on: October 10, 2016
14.1K
09:09Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
6.0K
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K
Tissue-Drug Binding: Localization of Drugs and its Significance
87
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
87
